World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
61
Citations
12855
World Ranking
3008
National Ranking
1196

Keith Henry publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Keith Henry sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 390 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Keith Henry D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Keith Henry sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 61 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Keith Henry is affiliated with Hennepin County Medical Center in the United States. Their research primarily focuses on the field of Medicine, with a notably strong emphasis on Infectious Diseases. Additional subfields of study include Epidemiology, Virology, Emergency Medicine, and General Health Professions.

The major topics addressed in their work revolve around HIV/AIDS, including research and interventions, drug development and treatment, and HIV-related health complications. Other specific topics include Pneumocystis jirovecii pneumonia detection and treatment, as well as Hepatitis C virus research.

Henry has published extensively within several scientific journals. Frequent publication venues for their work include Journal Watch, Open Forum Infectious Diseases, UNC Libraries, Open Journal of Clinical and Medical Case Reports, and Cureus.

Their recent notable papers include:

  • Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021, The Lancet HIV)
  • Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection (2023, NEJM Evidence)
  • Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria (2021, AIDS)
  • Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America (2020, UNC Libraries)
  • 1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine (2020, Open Forum Infectious Diseases)

Collaborations are a component of Henry's research activities, with frequent coauthors including Peter Ruane, Onyema Ogbuagu, David M. Asmuth, Richard Gilson, and Jason Brunetta. These collaborations appear across multiple studies and publications.

Best Publications

  • Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America.

    Jacob P. Lalezari;Keith Henry;Mary O'Hearn;Julio S.G. Montaner

  • Severe premature coronary artery disease with protease inhibitors

    Keith Henry;Holly Melroe;Jacquelyn Huebsch;Jessica Hermundson

  • Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

    Winston Cavert;Daan W. Notermans;Katherine Staskus;Stephen W. Wietgrefe

  • Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

    Edwin DeJesus;Jürgen K. Rockstroh;Keith Henry;Jean Michel Molina

  • Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial

    Richard T. D'Aquila;Michael D. Hughes;Victoria A. Johnson;Margaret A. Fischl

  • Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

    Alejo Erice;Douglas L. Mayers;David G. Strike;Kim J. Sannerud

  • Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities

    Keith Henry;Holly Melroe;Jacquelyn Huebesch;Jessica Hermundson

  • Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection

    Zhi Qiang Zhang;Daan W. Notermans;Gerald Sedgewick;Winston Cavert

  • Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

    Keith Henry;Herbert Cantrill;Courtney Fletcher;Barbara J. Chinnock

  • Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

    Jean Michel Molina;Bonaventura Clotet;Jan van Lunzen;Adriano Lazzarin

  • Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

    Herbert L. Cantrill;Keith Henry;N. Holly Melroe;William H. Knobloch

  • Indinavir concentrations and antiviral effect.

    Edward P. Acosta;Keith Henry;Leslie Baken;Linda M. Page

  • Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.

    Pablo Tebas;Amy K. Patick;Ellen M. Kane;Michael K. Klebert

  • Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

    Mark Nelson;Keikawus Arastéh;Bonaventura Clotet;David A. Cooper

  • High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy

    Kristin E. Mondy;John Gottdiener;E. Turner Overton;Keith Henry

  • Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000–2010

    Kate Buchacz;Bryan Lau;Yuezhou Jing;Ronald Bosch

  • The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

    Golnaz Namazi;Jesse M Fajnzylber;Evgenia Aga;Ronald J Bosch

  • Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy.

    Richard W. Price;Constantin T. Yiannoutsos;David B. Clifford;Lawrence Zaborski

  • Concentration-controlled compared with conventional antiretroviral therapy for HIV infection.

    Courtney V. Fletcher;Peter L. Anderson;Thomas N. Kakuda;Timothy W. Schacker

  • Risk of cancers during interrupted antiretroviral therapy in the SMART study.

    Michael J Silverberg;Jacqueline Neuhaus;Mark Bower;Daniela Gey

  • Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases

    Jason V. Baker;Jason V. Baker;Grace Peng;Joshua Rapkin;David Krason

  • Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.

    J B Jackson;S Y Kwok;J J Sninsky;J S Hopsicker

  • High-Density Lipoprotein Particles and Markers of Inflammation and Thrombotic Activity in Patients with Untreated HIV Infection

    Jason Baker;Woubeshet Ayenew;Woubeshet Ayenew;Harrison Quick;Katherine Huppler Hullsiek

Frequent Co-Authors

John T. Brooks
John T. Brooks Centers for Disease Control and Prevention
Pragna Patel
Pragna Patel Centers for Disease Control and Prevention
Henry H. Balfour
Henry H. Balfour University of Minnesota
Edward P. Acosta
Edward P. Acosta University of Alabama at Birmingham
Pablo Tebas
Pablo Tebas University of Pennsylvania
William G. Powderly
William G. Powderly Washington University in St. Louis
Elizabeth R. Unger
Elizabeth R. Unger Centers for Disease Control and Prevention
James D. Neaton
James D. Neaton University of Minnesota
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths that extend beyond traditional laboratory roles. For those interested in healthcare, pursuing an online health information management program offers a promising route. Many of these programs are online health information management programs cahiim accredited, ensuring quality education aligned with industry standards.

Graduates with expertise in health information management can explore careers as health information managers, a role valued for its critical function in managing patient data and healthcare systems. The healthcare information management salary is competitive, reflecting the growing demand for skilled professionals in this space.

Alternatively, those interested in clinical practice might consider becoming a functional medicine nurse. This specialization focuses on holistic patient care and requires advanced training. For more insight, explore the pathway to become a functional medicine nurse.

Additionally, careers in medical coding provide an essential backbone for healthcare administration. Certified professionals benefit from stable employment and lucrative pay. Learn more about the cpc medical coding salary and career opportunities to evaluate if this path suits your goals.

Best Scientists Citing Keith Henry

Trending Scientists

Recently Published Articles